Elevated Expression of the Stem Cell Marker CD133 Associated with Line-1 Demethylation in Hepatocellular Carcinoma

被引：0
|
作者：
Changsong Zhang
Yun Xu
Jun Zhao
Lieying Fan
Guocheng Jiang
Rong Li
Yang Ling
Mengchao Wu
Lixin Wei
机构：
[1] The Second Military Medical University,Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital
[2] Shanghai East Hospital,Department of Clinical Laboratory
[3] Tongji University Medical School,Clinical Oncology Laboratory
[4] Changzhou Tumor Hospital,undefined
[5] Medical College of Suzhou University,undefined
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
Cancer Stem Cell; Nontumor Tissue; Methylation Index; CD133 mRNA Expression; Nontumor Liver Tissue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2373 / 2380
页数：7
相关论文
共 50 条
  • [31] Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis
    Kazama, Shinsuke
    Kishikawa, Junko
    Kiyomatsu, Tomomichi
    Kawai, Kazushige
    Nozawa, Hiroaki
    Ishihara, Soichiro
    Watanabe, Toshiaki
    ASIAN JOURNAL OF SURGERY, 2018, 41 (03) : 274 - 278
  • [32] Prognostic significance of cancer stem cell marker CD133 expression in breast cancer
    Han, Linjun
    Gao, Xianshu
    Gu, Xiaobin
    Guo, Wei
    Ma, Mingwei
    Qi, Xin
    Cui, Ming
    Xie, Mu
    Bai, Yun
    Peng, Chuan
    Li, Xiaoying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (03): : 4829 - 4837
  • [33] Expression of CD44 and CD133 stem cell markers in squamous cell carcinoma of esophagus
    Gupta, Parul
    Rizvi, Sania Z.
    Lal, Nirupma
    Gupta, Vishal
    Srivastav, Anand N.
    Musa, Osman
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (03) : 472 - 478
  • [34] Hypomethylation of Long Interspersed Nuclear Element-1 (LINE-1) Leads to Activation of CD133 and ST18 in Hepatocellular Carcinoma
    Lee, Yu Rim
    Kim, Kyunghwa
    Park, Soo Young
    Keun, Hur
    Jang, Se Young
    Tak, Won Young
    Kweon, Young Oh
    Kang, Gyoun Eun
    Seo, Jong Won
    Park, Jung Gil
    Lee, Hye Won
    HEPATOLOGY, 2018, 68 : 1272A - 1273A
  • [35] Elevated stem cell marker CD133 mRNA in peripheral blood predicts colon cancer recurrence
    Lin, E. H.
    Hassan, M.
    Li, Y.
    Zhao, H.
    Nooka, A.
    Xie, K.
    Champlin, R.
    Wu, X.
    Li, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Stem cell marker CD133 / prominin-1 is expressed in gastric cancer
    Arao, Tokuzo
    Yamada, Yasuhide
    Taniguchi, Hirokazu
    Kawaishi, Makoto
    Kato, Terufumi
    Fukai, Junya
    Sakai, Kazuko
    Takeda, Masayuki
    Kimura, Hideharu
    Shimoyama, Tatsu
    Yokote, Hideyuki
    Nishio, Kazuto
    CANCER RESEARCH, 2006, 66 (08)
  • [37] Expression of Putative Stem Cell Markers ALDH1 and CD133 in Urothelial Carcinoma of the Bladder
    Matoso, A.
    Sciandra, K. T.
    Elsamra, S.
    Singh, K.
    Renzulli, J.
    Jacob, R.
    Tavares, R.
    Haleblian, G.
    Noble, L.
    Pareek, G.
    Resnick, M. B.
    Wang, L. J.
    MODERN PATHOLOGY, 2011, 24 : 210A - 210A
  • [38] Stem cell surface markers CD133 expression in hepatocellular carcinoma and as single prognostic factor for liver transplantation.
    Li, Yang
    Jiang, Nan
    Ruan, Dan-yun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Expression of the Stem Cell Marker CD133 (Prominin-1) in Eccrine and Apocrine Skin Tumors.
    Poblet, E.
    Nam-Cha, S. H.
    Serrano, R.
    Calero, R.
    Alfaro, L.
    MODERN PATHOLOGY, 2011, 24 : 123A - 124A
  • [40] High-level expression of the stem-cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis
    Kim, Kyungeun
    Ihm, Hyojin
    Ro, Jae Y.
    Kang, Sunghee
    Kang, Munjung
    Cho, Yong Mee
    CANCER RESEARCH, 2011, 71
12345